Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib.
Hiraoka A, Hirooka M, Koizumi Y, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Abe M, Matsuura B, Kawasaki H, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatol Res. 2017 May;47(6):558-565. doi: 10.1111/hepr.12780. Epub 2016 Aug 30. Hepatol Res. 2017. PMID: 27480045
Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2010 Feb;25(2):403-7. doi: 10.1111/j.1440-1746.2009.06037.x. Epub 2009 Nov 19. J Gastroenterol Hepatol. 2010. PMID: 19929922
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250. J Gastroenterol Hepatol. 2016. PMID: 26647219
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade.
Hiraoka A, Kumada T, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). Hiraoka A, et al. Among authors: kawasaki h. Hepatol Res. 2018 Feb;48(3):E61-E67. doi: 10.1111/hepr.12927. Epub 2017 Aug 2. Hepatol Res. 2018. PMID: 28628718
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
Hiraoka A, Otsuka Y, Kawasaki H, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Mori I, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19. J Gastroenterol Hepatol. 2018. PMID: 29193248
Zinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virus.
Hiraoka A, Nagamatsu K, Izumoto H, Adachi T, Yoshino T, Tsuruta M, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Suga Y, Mori K, Miyata H, Tsubouchi E, Ninomiya T, Kawasaki H, Hirooka M, Matsuura B, Abe M, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatol Res. 2020 Jan;50(1):92-100. doi: 10.1111/hepr.13430. Epub 2019 Nov 24. Hepatol Res. 2020. PMID: 31729124
Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2009 Jan-Feb;56(89):213-7. Hepatogastroenterology. 2009. PMID: 19453060
Hepatic resection assisted by ablative therapy for advanced hepatocellular carcinoma.
Hiraoka A, Tazuya N, Hidaka S, Uehara T, Ichiryu M, Nakahara M, Tanabe A, Shimizu Y, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Kawasaki H, Ochi H, Koizumi Y, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2011 May-Jun;58(107-108):955-9. Hepatogastroenterology. 2011. PMID: 21830423
Recent trends of Japanese hepatocellular carcinoma due to HCV in aging society.
Hiraoka A, Hidaka S, Shimizu Y, Utsunomiya H, Imai Y, Tatsukawa H, Tazuya N, Yamago H, Yorimitsu N, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Kawasaki H, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2012 Sep;59(118):1893-5. doi: 10.5754/hge11732. Hepatogastroenterology. 2012. PMID: 22193439
2,371 results